- Companies
- Evexia Lifecare
Evexia Lifecare Valuation Multiples
Evexia Lifecare is valued at $33M as of October 2026, a 5.8x revenue multiple. In the last fiscal year, Evexia Lifecare revenue was $12M and Evexia Lifecare EBITDA was $302K.
Evexia Lifecare Overview
About Evexia Lifecare
Evexia Lifecare is a listed Indian healthcare and pharmaceutical chemicals company. It trades industrial and pharmaceutical chemicals used in drug manufacturing, which is its largest business, and has moved from health and wellness products towards the pharmaceutical industry since 2020. The company also describes activities in retail pharmacy services, diagnostic solutions, personalised healthcare products and plastic reprocessing. It sells mainly to pharmaceutical manufacturers and chemical buyers, with some consumer-facing healthcare offerings. Revenue comes from trading margins on chemicals and from product sales. The company was established in 1990 and listed on the Bombay Stock Exchange in 1994, and it operates a manufacturing facility in Vadodara in Gujarat and a trading branch in Hyderabad. It has pursued growth through acquisitions in the pharmaceutical sector.
Founded
1990
HQ
Employees
10
Website
Financials (Last FY)
EV
$67M
Valuation Multiples
Start free trialEvexia Lifecare Financials
Evexia Lifecare reported last fiscal year revenue of $12M and EBITDA of $302K.
In the same fiscal year, Evexia Lifecare generated $604K in gross profit, $302K in EBITDA, and $170K in net income.
Evexia Lifecare P&L
In the most recent fiscal year, Evexia Lifecare reported revenue of $12M and EBITDA of $302K.
Evexia Lifecare is profitable as of last fiscal year, with gross margin of 5%, EBITDA margin of 3%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Evexia Lifecare Stock Performance
Evexia Lifecare has current market cap of $33M, and enterprise value of $67M.
Market Cap Evolution
Evexia Lifecare's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $67M | $33M | -4.8% | - | - | - | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEvexia Lifecare Valuation Multiples
Evexia Lifecare trades at 5.8x EV/Revenue multiple, and 223.2x EV/EBITDA.
Evexia Lifecare Financial Valuation Multiples
As of October 28, 2026, Evexia Lifecare has market cap of $33M and EV of $67M.
Evexia Lifecare has a P/E ratio of 191.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Evexia Lifecare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Evexia Lifecare Margins & Growth Rates
In the most recent fiscal year, Evexia Lifecare reported gross margin of 5%, EBITDA margin of 3%, and net margin of 1%.
Evexia Lifecare Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Evexia Lifecare Operational KPIs
Evexia Lifecare's revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Evexia Lifecare Competitors
Evexia Lifecare competitors include Amoeba, Mercan Kimya, Shriro Holdings, DCT Trading, American Vanguard, Cropmate, Maghreb Oxygene, Atlanta Poland, Birman Wood & Hardware and Alkemy Capital Investments.
Most Evexia Lifecare public comparables operate across Chemicals, Wholesale Distribution and Pharmacies.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | ($7M) | - | 6.4x | (6.2x) | (12.8x) | |||
| $58M | $10M | 1.1x | - | 6.4x | - | |||
| $78M | $13M | 0.4x | - | 2.6x | - | |||
| $54M | ($591K) | 0.7x | - | (63.0x) | - | |||
| $515M | ($10M) | 0.5x | 0.5x | (27.2x) | 6.9x | |||
| $48M | $5M | 0.7x | 0.7x | 6.1x | 6.2x | |||
| - | - | - | - | - | - | |||
| $134M | $7M | 0.3x | - | 5.2x | - | |||
This data is available for Pro users. Sign up to see all Evexia Lifecare competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Evexia Lifecare
Evexia Lifecare has acquired 1 company to date.
Last acquisition by Evexia Lifecare was on October 7th 2026. Evexia Lifecare acquired Reponex Pharmaceuticals for $7M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Evexia Lifecare
| Description | Reponex Pharmaceuticals is a Danish clinical-stage pharmaceutical company that repositions existing drugs to treat difficult-to-treat diseases. Its drug candidates target peritonitis, chronic skin ulcers, Crohn's disease and pouchitis, and colorectal cancer and colon adenomas. The company works with academic and industry partners on development. Its parent, Pharma Equity Group, is listed on Nasdaq Copenhagen and approved a transaction with Reponex in February 2023. Reponex draws on the parent's expertise in life sciences, investment and business development, and it has no commercial products yet. |
| HQ Country | |
| HQ City | Copenhagen |
| Deal Date | 7 Oct 2026 |
| Valuation | $7M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Evexia Lifecare acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Evexia Lifecare
| When was Evexia Lifecare founded? | Evexia Lifecare was founded in 1990. |
| Where is Evexia Lifecare headquartered? | Evexia Lifecare is headquartered in India. |
| How many employees does Evexia Lifecare have? | As of today, Evexia Lifecare has over 10 employees. |
| Is Evexia Lifecare publicly listed? | Yes, Evexia Lifecare is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Evexia Lifecare? | Evexia Lifecare trades under 524444 ticker. |
| When did Evexia Lifecare go public? | Evexia Lifecare went public in 2012. |
| Who are competitors of Evexia Lifecare? | Evexia Lifecare main competitors include Amoeba, Mercan Kimya, Shriro Holdings, DCT Trading, American Vanguard, Cropmate, Maghreb Oxygene, Atlanta Poland, Birman Wood & Hardware, Alkemy Capital Investments. |
| What is the current market cap of Evexia Lifecare? | Evexia Lifecare's current market cap is $33M. |
| What is the current revenue of Evexia Lifecare? | Evexia Lifecare's last fiscal year revenue is $12M. |
| What is the current EV/Revenue multiple of Evexia Lifecare? | Current revenue multiple of Evexia Lifecare is 5.8x. |
| Is Evexia Lifecare profitable? | No, Evexia Lifecare is not profitable. |
| How many companies Evexia Lifecare has acquired to date? | As of October 2026, Evexia Lifecare has acquired 1 company. |
| What was the largest acquisition by Evexia Lifecare? | $7M acquisition of Reponex Pharmaceuticals on 7th October 2026 was the largest M&A Evexia Lifecare has done to date. |
| What companies Evexia Lifecare acquired? | Evexia Lifecare acquired Reponex Pharmaceuticals. |
| In how many companies Evexia Lifecare has invested to date? | Evexia Lifecare hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Evexia Lifecare
Lists including Evexia Lifecare
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




